Lou Lu (Echinops Root or Rhaponticum)

Chinese Herb Actions

Chinese Herb Dosage

• What is the typical dosage of Lou Lu?

  Roughly 3–12 g is the range carried in our reference record, using the dried root.

  • Part used — the root.
  • Which root, though, is the substantive question — see the identity section below. Two different plants are supplied under this name, and a dosage figure is only meaningful once the botanical source is settled.

  Source: Sacred Lotus sources & references; standard materia medica dosage notes (Bensky; Chen & Chen).

Chinese Herb Contraindications & Cautions

• Are there cautions for Lou Lu?

  Lou Lu is contraindicated during pregnancy and in patients with qi deficiency, per our reference record. Those two restrictions follow directly from its nature: it is cold, draining and moving, which suits an acute heat-and-toxin presentation and works against a depleted or pregnant patient.

  • Pregnancy — contraindicated.
  • Qi deficiency — contraindicated.
  • Cold or yin-type sores — as with heat-clearing, toxin-resolving herbs generally, it is matched to hot, red, acute presentations rather than to pale, chronic, cold ones.
  • Botanical source — the identity question set out above is a legitimate quality-control matter for this herb. Where a formula's effect depends on Lou Lu specifically, knowing which of the two plants was supplied is worth establishing with the supplier.

  Source: Sacred Lotus cautions record (pregnancy; qi deficiency); category-level cautions per standard materia medica (Bensky; Chen & Chen). Neutral reference facts, not usage instructions.

Chinese Herb Toxicity & Overdose

• Low. Lou Lu is not classified as toxic in our properties record, and neither botanical source has an established toxicity profile in the traditional literature at customary doses. The honest qualifier is that the modern evidence base is thin on this point rather than reassuring: a 2022 comprehensive review of Rhaponticum uniflorum states that the published research on its metabolites and bioactivity does not include clinical studies of extracts or pure compounds, and calls for accurate study of the plant. Absence of reported toxicity here reflects limited investigation, not demonstrated safety.

  Source: Sacred Lotus properties record; state of the evidence per PMID 36421734, PMC 9687929, DOI 10.3390/biom12111720. Reference note, not a safety guarantee.

Herb-Drug Interactions

• No well-established clinical herb–drug interactions are documented for Lou Lu in sources we could verify. This reflects the limited state of the research literature — no clinical studies of either botanical source were identified — rather than a demonstration that none exist. (Flagged for practitioner confirmation.)

Western / Biomedical Research

Chinese Herb Clinical Studies & Research

Provided as research context — a summary of published biomedical study, not a therapeutic or medical claim.

• Is there modern research on Lou Lu (Rhaponticum uniflorum / Echinops latifolius)?

  Yes, and the single most striking finding lines up with the herb's oldest indication: an ethanol extract of Rhapontici Radix — Rhaponticum uniflorum root — reduced mammary inflammation in both cells and mice. Beyond that, the two botanical sources have largely separate literatures, which is itself evidence that they are chemically distinct herbs.

  • Mastitis (cell and animal) — a 2024 study in the Journal of Ethnopharmacology tested Rhaponticum uniflorum root ethanol extract against lipopolysaccharide-induced mammary inflammation. Both the extract and its major antioxidant constituent, isochlorogenic acid B, reduced T-lymphocyte infiltration in mouse mammary glands and lowered COX-2, iNOS, TNF-alpha, IL-6 and IL-1beta in bovine mammary alveolar cells, acting through the MAPK and NF-kappaB pathways. Isochlorogenic acid B accounted for 84% of the extract's radical-scavenging activity. This is an animal and cell study of a breast-inflammation model — the closest modern correlate of the classical mastitis and breast-abscess indication.
  • Constituents of Rhaponticum uniflorum — a 2022 review in Biomolecules catalogued 225 compounds from the plant, including sesquiterpenes, ecdysteroids, triterpenes, sterols, thiophenes, hydroxycinnamates, flavonoids and lignans, with reported anti-inflammatory, antitumour, immunostimulatory, stress-protective and hepatoprotective activity in laboratory models. The review states plainly that no clinical studies exist.
  • Constituents of Echinops latifolius — a 2024 review in Molecules of Echinopsis Radix catalogued 85 compounds, of which 49 are thiophenes; thiophenes are described as the main secondary metabolites and carry the antitumour, insecticidal and antifungal activity reported for this source. Separate phytochemical work has isolated dimeric sesquiterpenes and thiophenes from the roots with inhibitory effects on nitric-oxide production in stimulated macrophages.
  • Why that matters for identity — the compound classes differ. The 2010 quality-control study relied on exactly this: fourteen of nineteen commercial “Radix Echinopsis” batches were identified as Radix Rhapontici because they lacked the characteristic thiophenes.

  All of the above is laboratory or animal research. It is consistent with the traditional heat-clearing use and with the breast-focused indication in particular, but it is not clinical evidence.

  Sources: PMID 38942158, DOI 10.1016/j.jep.2024.118462 (Rhapontici Radix in mastitis models, cell and mouse); PMID 36421734, PMC 9687929, DOI 10.3390/biom12111720 (Rhaponticum uniflorum review, 225 compounds, no clinical studies); PMID 38792128, PMC 11124464, DOI 10.3390/molecules29102267 (Echinopsis Radix review, thiophenes); PMID 27865705, DOI 10.1016/j.bmcl.2016.10.017 (dimeric sesquiterpene and thiophenes from Echinops latifolius roots, in-vitro); PMID 20112306, DOI 10.1002/jssc.200900613 (commercial batch identity and alpha-terthienyl content); PMID 1294172 (textual study of the classical origin of Loulu). Research context, not a therapeutic claim.

Chinese Herb Notes

• Is Lou Lu Rhaponticum or Echinops? Why does it have two botanical sources?

  Both, in practice — and our own record says so. Our Latin name for this herb is Radix Rhapontici seu Echinopsis, which translates as “root of Rhaponticum or Echinops”. Rhaponticum uniflorum is the historically grounded source; Echinops latifolius is a second, regionally used article that has been carried alongside it in the Chinese Pharmacopoeia. This is a genuine multi-source situation, not a mistake in our data.

  What the two plants actually are:

  • Rhaponticum uniflorum (L.) DC. — the historically supported source. A member of the Compositae (Asteraceae). Its dried root supplies the article known pharmaceutically as Rhapontici Radix, and it is also called Qi Zhou Lou Lu. It is used across China, Siberia and Mongolia as an anti-inflammatory remedy. A 1992 textual study of Lou Lu in the classical Chinese herbals concluded that the botanical origin of Lou Lu “should be Qizhou Loulu, the dried root of Rhaponticum uniflorum”.
  • Echinops latifolius Tausch — the regional second source. Also Compositae; its dried root supplies Echinopsis Radix, circulating under the name Yu Zhou Lou Lu. The Chinese Pharmacopoeia records Echinopsis Radix as the roots of Echinops latifolius or Echinops grijsii. Chemically it is a different herb: its characteristic constituents are thiophenes, notably alpha-terthienyl, which Rhaponticum material does not supply in the same way.

  The honest position, stated plainly. The same 1992 textual study that identified Rhaponticum uniflorum as the historical Lou Lu argued that Echinops latifolius “should not be used as Loulu because of its deficiency of herbal evidences and totally different chemical constituents”, and recommended its removal from the Pharmacopoeia. That recommendation was not adopted; the Echinops article remains official under its own name. So the two are best understood as two related but distinct medicinals that share a traditional name, rather than as interchangeable grades of one herb. The naming problem is acknowledged at the regulatory level: a study of the 2020 Chinese Pharmacopoeia revisions lists Echinopsis Radix among the medicinal materials whose Chinese name did not match its Latin scientific name or its actual botanical origin, and which were revised on that basis. Our record names both origins, which is accurate; readers should be aware that a supplier's “Lou Lu” may be either plant.

  Substitution runs in both directions in the marketplace. A 2010 chromatographic study analysed nineteen commercial batches sold as Radix Echinopsis and found that only five were the correct species; the other fourteen were identified as Radix Rhapontici, distinguishable because they lacked the characteristic thiophenes. Alpha-terthienyl content in the five genuine batches ranged from 2.7 to 5.2 mg/g. That is the practical measure of how blurred the boundary has become.

  Name meaning: our record translates Lou Lu as “Leaking Reed”.

  Source: Sacred Lotus sources & references (our Latin Radix Rhapontici seu Echinopsis, Chinese name and translation as held); textual study of the classical origin of Loulu per PMID 1294172; Rhaponticum uniflorum as Rhapontici Radix per PMID 38942158, DOI 10.1016/j.jep.2024.118462 and PMID 36421734, PMC 9687929, DOI 10.3390/biom12111720; Echinopsis Radix pharmacopoeial origins and thiophene chemistry per PMID 38792128, PMC 11124464, DOI 10.3390/molecules29102267; commercial substitution data per PMID 20112306, DOI 10.1002/jssc.200900613; 2020 Pharmacopoeia origin revisions per PMID 34047111, DOI 10.19540/j.cnki.cjcmm.20210226.104. Cross-referenced against multiple online sources.